The Claudin 18.2 Targeted Therapy market size is expected to reach $4.61 billion in 2030 at a CAGR of 23.5%, driven by rising gastrointestinal cancer cases.
Read More
The Chronic Traumatic Encephalopathy market size is expected to reach $2.27 billion in 2030 at a CAGR of 8.4%, driven by rising head injury cases.
Read More
The Chronic Pain Treatment market size is expected to reach $168.99 billion in 2030 at a CAGR of 9.1%, driven by rising arthritis pain prevalence.
Read More
The Chronic Obstructive Pulmonary Disease (COPD) Treatment market size is expected to reach $29.13 billion in 2030 at a CAGR of 6.2%, driven by rising smoking prevalence.
Read More
The Chronic Lymphocytic Leukemia Treatment market size is expected to reach $23.74 billion in 2030 at a CAGR of 8.9%, driven by rising CLL prevalence.
Read More
The Cholinesterase (ChE) Inhibitors market size is expected to reach $5.99 billion in 2030 at a CAGR of 7.3%, driven by rising Alzheimer’s disease prevalence.
Read More
The Cholinergic Drugs market size is expected to reach $9.58 billion in 2030 at a CAGR of 3.4%, driven by rising neurological disorder prevalence.
Read More
The Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy market size is expected to reach $3.28 billion in 2030 at a CAGR of 6.2%, driven by rising cancer incidence.
Read More
The Chimeric Antibody market size is expected to reach $23.73 billion in 2030 at a CAGR of 11.5%, driven by rising cancer prevalence.
Read More
The Chickenpox Vaccine market size is expected to reach $5.12 billion in 2030 at a CAGR of 6.4%, driven by growing vaccination awareness.
Read More